Early Outcomes With Marginal Donor Hearts Compared With Left Ventricular Assist Device Support in Patients With Advanced Heart Failure Erin M. Schumer,

Slides:

Advertisements

Similar presentations

Heart Transplant vs Left Ventricular Assist Device in Heart Transplant-Eligible Patients Matthew L. Williams, MD, Jaimin R. Trivedi, MD, MPH, Kelly C.

Advertisements

Fenton H. McCarthy, MD, Dale Kobrin, BA, J. Eduardo Rame, MD, Peter W

What Predicts Long-Term Survival After Heart Transplantation

Pulmonary Lobectomy in a Patient With a Left Ventricular Assist Device

Adam N. Protos, MD, Jaimin R. Trivedi, MD, MPH, William M

Surgically Corrected Mitral Regurgitation During Left Ventricular Assist Device Implantation Is Associated With Low Recurrence Rate and Improved Midterm.

Survival on the Heart Transplant Waiting List: Impact of Continuous Flow Left Ventricular Assist Device as Bridge to Transplant Jaimin R. Trivedi, MD,

Outcomes of Reintervention on the Autograft After Ross Procedure

Implantation of HeartMate II Left Ventricular Assist Device in a Single-Lung Patient Hannah Copeland, MD, Liset Stoletniy, MD, Antoine Sakr, MD, Anees.

Berlin Heart EXCOR Ventricular Assist Device: Multilayer Membrane Rupture in a Pediatric Patient Arianna Di Molfetta, PhD, Sergio Filippelli, PhD, Gianfranco.

Preoperative Aspirin Use and Its Effect on Adverse Events in Patients Undergoing Cardiac Operations Jiapeng Huang, MD, PhD, Macarius Donneyong, PhD,

Laura Harvey, MD, Christopher Holley, MD, Samit S

Lisa M. Brown, MD, MAS, David T. Cooke, MD, Elizabeth A. David, MD

Video-Assisted Thoracoscopic Left Ventricular Pacing in Patients With and Without Previous Sternotomy Katharine E. Nelson, MBBS, MRCP, Matthew G.D. Bates,

Dhaval Chauhan, MD, Alexis K

ABO-Identical Blood Group Matching Has No Survival Benefit for AB Heart Transplant Recipients Henrik Bergenfeldt, MD, Peter Höglund, MD, PhD, Bodil Andersson,

Biventricular Conversion After Single Ventricle Palliation in Patients With Small Left Heart Structures: Short-Term Outcomes Brian T. Kalish, MD, Puja.

Extracorporeal Membrane Oxygenation is Superior to Right Ventricular Assist Device for Acute Right Ventricular Failure After Heart Transplantation Shahrokh.

Less Is More in Post Pediatric Heart Transplant Care

Operative Results and Outcomes in Children With Shone's Anomaly

Denton A. Cooley, August 22, 1920, to November 18, 2016

Fenton H. McCarthy, MD, Dale Kobrin, BA, J. Eduardo Rame, MD, Peter W

Matthew L. Williams, MD, Jaimin R. Trivedi, MD, MPH, Kelly C

Prior Sternotomy and Ventricular Assist Device Implantation Do Not Adversely Impact Survival or Allograft Function After Heart Transplantation Ann C.

Ventricular assist device programs: design and function

Allen Cheng, MD, Erin M. Schumer, MD, MPH, Jaimin R

Continuous-Flow Left Ventricular Assist Device Implantation in Patients With a Small Left Ventricle Masashi Kawabori, MD, Chitaru Kurihara, MD, Tadahisa.

Use of Amiodarone After Major Lung Resection

Elliot Wakeam, MD, MPH, James P. Byrne, MD, Gail E

Discussions in Cardiothoracic Treatment and Care: Mechanical Circulatory Support Left Ventricular Assist Device Therapy for Patients With Advanced Heart.

Jaimin R. Trivedi, MD, MPH, Allen Cheng, MD, Michele Gallo, MD, Erin M

Should Patients 60 Years and Older Undergo Bridge to Transplantation With Continuous-Flow Left Ventricular Assist Devices? Jeremiah G. Allen, MD, Arman.

Outcomes on Continuous Flow Left Ventricular Assist Devices: A Single Institutional 9- Year Experience Jeffrey A. Morgan, MD, Pauline H. Go, MD, Linnea.

Nicholas A. Haglund, MD, Mary E. Davis, MS, CCRP, Nicole M

Michiaki Imamura, MD, PhD, Amy M

Acute Kidney Injury Increases Mortality After Lung Transplantation

Kathryn E. Engelhardt, MD, Malcolm M. DeCamp, MD, Anthony D

Eric S. Weiss, MD, MPH, Jeremiah G. Allen, MD, Christian A

Colonization With Multiresistant Bacteria: Impact on Ventricular Assist Device Patients Maria Papathanasiou, MD, Julia Pohl, MD, Rolf Alexander Jánosi,

Arman Kilic, MD, Eric S. Weiss, MD, MPH, Jeremiah G

Right Heart Dysfunction After Left Ventricular Assist Device Implantation: A Comparison of the Pulsatile HeartMate I and Axial-Flow HeartMate II Devices

Posttransplant Outcomes Among Septuagenarians Bridged to Transplantation With Continuous-Flow Left Ventricular Assist Devices Shinichi Fukuhara, MD,

Mechanical Circulatory Support Pathways That Maximize Post-Heart Transplant Survival Tara Karamlou, MD, MS, Jill Gelow, MD, Brian S. Diggs, PhD, Frederick.

Dhaval Chauhan, MD, Alexis K

William M. Whited, MD, Paul Henley, BS, Erin M

Mechanical Circulatory Support and Heart Transplantation: Donor and Recipient Factors Influencing Graft Survival Simon Maltais, MD, PhD, Nikhil P. Jaik,

Listing Low-Weight or Ill Infants for Heart Transplantation: Is It Prudent? Raheel Rizwan, MD, Farhan Zafar, MD, Clifford Chin, MD, James Tweddell, MD,

Single Versus Double Lung Retransplantation Does Not Affect Survival Based on Previous Transplant Type Erin M. Schumer, MD, MPH, Jonathan D. Rice, MD,

Adhering to Quality Measures in Esophagectomy Is Associated With Improved Survival in All Stages of Esophageal Cancer Pamela Samson, MD, MPHS, Varun.

Survival After Isolated Coronary Artery Bypass Grafting in Patients With Severe Left Ventricular Dysfunction Waleed A. Ahmed, MD, Phillip J. Tully, BHSc(Hons),

Is There a Benefit to Prolonging the Interval Between Neoadjuvant Chemoradiation and Esophagectomy in Esophageal Cancer? Anna Lee, MD, MPH, Andrew T.

Is severe right ventricular failure in left ventricular assist device recipients a risk factor for unsuccessful bridging to transplant and post-transplant.

Minimally Invasive Surgical Alternatives for Left Ventricle Epicardial Lead Implantation in Heart Failure Patients José L. Navia, MD, Fernando A. Atik,

Scott B. Johnson, MD, Anna M. Allred, BS, Adam M. Cline, MD, Luis F

Trends in Patient Characteristics and Outcomes of Coronary Artery Bypass Grafting in the 2000 to 2012 Medicare Population Christian McNeely, MD, Stephen.

The Impact of Volume Reduction on Early and Long-Term Outcomes in Surgical Ventricular Restoration for Severe Heart Failure Nathan Wm. Skelley, BS, Jeremiah.

Postcardiac transplant survival in the current era in patients receiving continuous-flow left ventricular assist devices Forum Kamdar, MD, Ranjit John,

Improved Survival and Decreasing Incidence of Adverse Events With the HeartMate II Left Ventricular Assist Device as Bridge-to-Transplant Therapy Ranjit.

Farhan Zafar, MD, John L. Jefferies, MD, MPH, Christine J

Iki Adachi, MD, Muhammad S. Khan, MD, Francisco A

Late Aortic Insufficiency Related to Poor Prognosis During Left Ventricular Assist Device Support Koichi Toda, MD, PhD, Tomoyuki Fujita, MD, Keitaro.

Creation of a Quantitative Score to Predict the Need for Mechanical Support in Children Awaiting Heart Transplant Ryan R. Davies, MD, Shylah Haldeman,

Infectious Complications in Patients With Left Ventricular Assist Device: Etiology and Outcomes in the Continuous-Flow Era Veli K. Topkara, MD, Sreekanth.

Y. Joseph Woo, MD, Michael A. Acker, MD The Annals of Thoracic Surgery

Ventricular Assist Device Implant in the Elderly Is Associated With Increased, but Respectable Risk: A Multi-Institutional Study Pavan Atluri, MD, Andrew.

Costs Associated With Ventricular Assist Device Use in Children

Nosocomial bloodstream infections in patients with implantable left ventricular assist devices Steven M Gordon, MD, Steven K Schmitt, MD, Micah Jacobs,

Marginal Donor Use in Patients Undergoing Heart Transplantation With Left Ventricular Assist Device Explantation Marat Fudim, MD, Mary E. Davis, MS,

Heart Transplant Program Volume Is Not a Measure of Quality

Significance of Postoperative Acute Renal Failure After Continuous-Flow Left Ventricular Assist Device Implantation Jamil Borgi, MD, Athanasios Tsiouris,

Presentation transcript:

Early Outcomes With Marginal Donor Hearts Compared With Left Ventricular Assist Device Support in Patients With Advanced Heart Failure Erin M. Schumer, MD, Mickey S. Ising, MEng, Jaimin R. Trivedi, MD, MPH, Mark S. Slaughter, MD, Allen Cheng, MD The Annals of Thoracic Surgery Volume 100, Issue 2, Pages 522-527 (August 2015) DOI: 10.1016/j.athoracsur.2015.02.089 Copyright © 2015 The Society of Thoracic Surgeons Terms and Conditions

Fig 1 Flow chart of selection of patients for analysis using the United Network for Organ Sharing database. The left-ventricular assist device group, n = 2,561; marginal donor group, n = 4,737. (HMII = Heart-Mate II; HVAD = heart ventricular assist device; MCS = mechanical circulatory support device.) The Annals of Thoracic Surgery 2015 100, 522-527DOI: (10.1016/j.athoracsur.2015.02.089) Copyright © 2015 The Society of Thoracic Surgeons Terms and Conditions

Fig 2 Annual case count from 2005 to 2013 for left ventricular assist device (LVAD) placement and marginal donor heart transplantations. The LVAD cases are counted at time of listing while marginal donor heart transplantations are counted at time of transplant. The Annals of Thoracic Surgery 2015 100, 522-527DOI: (10.1016/j.athoracsur.2015.02.089) Copyright © 2015 The Society of Thoracic Surgeons Terms and Conditions

Fig 3 Kaplan-Meier survival analysis comparing all-cause mortality for continuous flow left ventricular assist device (LVAD) pre-transplant recipients and recipients of marginal donor hearts post-transplantation. The Annals of Thoracic Surgery 2015 100, 522-527DOI: (10.1016/j.athoracsur.2015.02.089) Copyright © 2015 The Society of Thoracic Surgeons Terms and Conditions

Fig 4 Kaplan-Meier survival analysis comparing all-cause mortality for post-transplantation survival for patients implanted with a left ventricular assist device (LVAD) and recipients of marginal donor hearts. The Annals of Thoracic Surgery 2015 100, 522-527DOI: (10.1016/j.athoracsur.2015.02.089) Copyright © 2015 The Society of Thoracic Surgeons Terms and Conditions